Catalyst Wire Dossier Catalyst Wire Dossier

XIAP antisense oligonucleotide

XIAP antisense oligonucleotide · Aegera Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIAP antisense oligonucleotide, covering 2008-08-21 to 2008-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of XIAP Antisense for Advanced Cancers [Phase 1]

See pricing